OTCMKTS:FPMI - Fluoropharma Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0950 -0.01 (-9.52 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$0.10
Today's Range$0.09 - $0.0950
52-Week Range$0.0296 - $0.15
Volume27,500 shs
Average Volume12,273 shs
Market Capitalization$3.25 million
P/E RatioN/A
Dividend YieldN/A
Beta3.27
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.

Receive FPMI News and Ratings via Email

Sign-up to receive the latest news and ratings for FPMI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:FPMI
CUSIPN/A
Phone973-744-1565

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$3.25 million
OptionableNot Optionable

Fluoropharma Medical (OTCMKTS:FPMI) Frequently Asked Questions

What is Fluoropharma Medical's stock symbol?

Fluoropharma Medical trades on the OTCMKTS under the ticker symbol "FPMI."

How were Fluoropharma Medical's earnings last quarter?

Fluoropharma Medical Inc (OTCMKTS:FPMI) posted its quarterly earnings results on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.01. View Fluoropharma Medical's Earnings History.

Has Fluoropharma Medical been receiving favorable news coverage?

News headlines about FPMI stock have trended positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Fluoropharma Medical earned a coverage optimism score of 2.3 on InfoTrie's scale. They also gave headlines about the biopharmaceutical company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the near term.

Who are some of Fluoropharma Medical's key competitors?

Who are Fluoropharma Medical's key executives?

Fluoropharma Medical's management team includes the folowing people:
  • Dr. Thomas H. Tulip, CEO, Pres & Director (Age 66)
  • Ms. Tamara Rhein, Chief Financial Officer (Age 47)
  • Mr. Edward L. Lyons Jr., VP of Devel.

How do I buy shares of Fluoropharma Medical?

Shares of FPMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fluoropharma Medical's stock price today?

One share of FPMI stock can currently be purchased for approximately $0.0950.

How big of a company is Fluoropharma Medical?

Fluoropharma Medical has a market capitalization of $3.25 million.

What is Fluoropharma Medical's official website?

The official website for Fluoropharma Medical is http://www.fluoropharma.com.

How can I contact Fluoropharma Medical?

Fluoropharma Medical's mailing address is 8 Hillside Avenue Suite 108, Montclair NJ, 07042. The biopharmaceutical company can be reached via phone at 973-744-1565 or via email at [email protected]


MarketBeat Community Rating for Fluoropharma Medical (OTCMKTS FPMI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Fluoropharma Medical and other stocks. Vote "Outperform" if you believe FPMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FPMI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel